Literature DB >> 27538007

Oral Lichen Planus Treated With Apremilast.

Miriam Bettencourt.   

Abstract

Oral lichen planus is a very difficult condition to treat and causes patients to experience pain and difficulty eating. Therapeutic approaches focus on minimizing flares and relieving pain and discomfort to improve patient quality of life. Topical preparations are the mainstay of therapy, but they are often insufficiently efficacious for more severe cases. The use of systemic agents can be complicated by potentially serious adverse effects, the need for regular monitoring, suboptimal efficacy, and cost. Reported here are 3 recalcitrant cases of oral lichen planus that were effectively treated with apremilast, a drug recently approved for psoriasis and psoriatic arthritis.<br /><br /> <em>J Drugs Dermatol</em>. 2016;15(8):1026-1028.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27538007

Source DB:  PubMed          Journal:  J Drugs Dermatol        ISSN: 1545-9616            Impact factor:   2.114


  7 in total

1.  Off-label studies on apremilast in dermatology: a review.

Authors:  Nolan J Maloney; Jeffrey Zhao; Kyle Tegtmeyer; Ernest Y Lee; Kyle Cheng
Journal:  J Dermatolog Treat       Date:  2019-04-02       Impact factor: 3.359

2.  Treatment of recalcitrant erosive oral lichen planus and desquamative gingivitis with oral apremilast.

Authors:  Mohn'd AbuHilal; Scott Walsh; Neil Shear
Journal:  J Dermatol Case Rep       Date:  2016-11-30

Review 3.  Therapeutic targeting of 3',5'-cyclic nucleotide phosphodiesterases: inhibition and beyond.

Authors:  George S Baillie; Gonzalo S Tejeda; Michy P Kelly
Journal:  Nat Rev Drug Discov       Date:  2019-08-06       Impact factor: 84.694

Review 4.  Acquired White Oral Lesions with Specific Patterns: Oral Lichen Planus and Lupus Erythematosus.

Authors:  Marco Manfredini; Gioia Pedroni; Laura Bigi; Roberto Apponi; Alberto Murri Dello Diago; Annunziata Dattola; Francesca Farnetani; Giovanni Pellacani
Journal:  Dermatol Pract Concept       Date:  2021-05-20

Review 5.  Therapeutic strategies for oral lichen planus: State of the art and new insights.

Authors:  Dario Didona; Raffaele Dante Caposiena Caro; Antonio Manuel Sequeira Santos; Farzan Solimani; Michael Hertl
Journal:  Front Med (Lausanne)       Date:  2022-10-04

6.  Apremilast for genital erosive lichen planus in women (the AP-GELP Study): study protocol for a randomised placebo-controlled clinical trial.

Authors:  Kristin Helene Skullerud; Petter Gjersvik; Are Hugo Pripp; Erik Qvigstad; Anne Lise Ording Helgesen
Journal:  Trials       Date:  2021-07-20       Impact factor: 2.279

Review 7.  Oral lichen planus: a novel staging and algorithmic approach and all that is essential to know.

Authors:  Eran Shavit; Klieb Hagen; Neil Shear
Journal:  F1000Res       Date:  2020-03-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.